文献速递其他结缔组织病

系统性硬化症患者中产生白介素-6的过渡型B淋巴细胞自身反应性调节缺陷与疾病的关联

Association of Defective Regulation of Autoreactive Interleukin-6-Producing Transitional B Lymphocytes With Disease in Patients With Systemic Sclerosis.
PubMed 文献 · Arthritis Rheumatol · 2018-02-06

本研究采用多色流式细胞术检测系统性硬化症(SSc)患者与健康对照的B细胞亚群分布、细胞因子产生及耐受诱导,发现SSc B细胞存在过渡型B细胞亚群分布改变、白介素-6(IL-6)与IL-8产生增加、耐受诱导缺陷,且经先天免疫途径刺激后产生IL-10能力降低;与健康个体不同,SSc患者耐受检查点未能抑制针对Scl-70抗原产生自身抗体的B细胞出现,这些缺陷伴随B细胞受体 engagement 后细胞内信号与凋亡改变。

要点

  • SSc患者B细胞存在过渡型B细胞亚群分布改变及耐受诱导缺陷。
  • SSc患者B细胞产生IL-6与IL-8增加,经先天免疫途径刺激后产生IL-10能力降低。
  • SSc患者耐受检查点未能抑制针对Scl-70抗原产生自身抗体的B细胞出现。

核心结论

  • 本研究为SSc患者B淋巴细胞反应缺陷的机制及其在疾病中的作用提供了新见解。

研究设计与样本

  • 研究采用多色流式细胞术检测SSc患者与健康对照的B细胞亚群分布、细胞因子产生及耐受诱导,并通过多重检测法测定细胞体外刺激后的细胞因子产生。

主要发现

  • SSc患者存在B淋巴细胞耐受与细胞因子产生的一系列缺陷,包括过渡型B细胞亚群分布改变、IL-6与IL-8产生增加及耐受诱导缺陷。
  • SSc患者B细胞经先天免疫途径刺激后产生IL-10的能力降低。
  • 与健康个体不同,SSc患者耐受检查点未能抑制针对Scl-70抗原产生自身抗体的B细胞出现,该抗原与SSc强相关。
  • 上述缺陷伴随B细胞受体 engagement 后细胞内信号与凋亡的改变。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Systemic sclerosis (SSc) has the highest case-specific mortality of any rheumatic disease, and no effective therapy is available. A clear manifestation of SSc is the presence of autoantibodies. However, the origin of autoantibody-producing B lymphocytes, their mechanisms of activation and autoantibody production, and their role remain unclear. This study was undertaken to identify mechanisms that contribute to pathogenic B cell generation and involvement in SSc and to assess the altered distribution and function of B cells in SSc patients. METHODS: Multicolor flow cytometry was performed to determine B cell subset distribution, cytokine production, and tolerance induction in SSc patients and healthy controls. Cytokine production following stimulation of the cells ex vivo was determined by multiplex assay. RESULTS: A range of defects in B lymphocyte tolerance and cytokine production in SSc were noted. There was evidence of altered distribution of transitional B cell subsets, increased production of interleukin-6 (IL-6) and IL-8, and defective tolerance induction in SSc B cells. In addition, B cells from SSc patients had a reduced ability to produce IL-10 when stimulated through innate immune pathways. In contrast to healthy individuals, tolerance checkpoints in SSc patients failed to suppress the emergence of B cells that produce autoantibodies with specificity to the Scl-70 antigen, which is strongly associated with SSc. These defects were paralleled by altered intracellular signaling and apoptosis following B cell receptor engagement. CONCLUSION: Our findings provide new insights into mechanisms underlying defective B lymphocyte responses in patients with SSc and their contribution to disease.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Taher TE, Ong VH, Bystrom J, et al. Association of Defective Regulation of Autoreactive Interleukin-6-Producing Transitional B Lymphocytes With Disease in Patients With Systemic Sclerosis. Arthritis Rheumatol. 2018. PMID: 29193892. doi:10.1002/art.40390

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。